Biological Sex
Biological sex is a fundamental biological attribute in humans and other species, typically defined by chromosomal, anatomical, and physiological characteristics. While often simplified to a binary of male and female, its biological underpinnings are complex, involving a wide array of genetic and hormonal factors. Genetic analyses have revealed that while sex chromosomes (X and Y) play a primary role in sex determination, autosomal genetic variants also contribute significantly to sex-related biological differences and can influence phenotypes in a sex-differential manner. [1] Understanding the biological basis of sex is crucial for interpreting genetic influences on health, disease, and behavior.
Biological Basis
At a fundamental level, biological sex in humans is primarily determined by the presence of sex chromosomes: XX typically results in female development, and XY typically results in male development. However, genetic studies extend beyond this, identifying a substantial number of autosomal signals that show significant allele frequency differences between sexes. [1] These genetic variants on non-sex chromosomes can influence sex-differential participation in studies and are associated with a wide range of complex traits. [1] For instance, the basic helix-loop-helix transcription factor TCF21 is a known downstream target of the male sex-determining gene SRY. [2]
The genetic architecture of many traits is observed to be sex-specific, meaning genetic influences can differ between males and females. This has been demonstrated in studies on various traits, including same-sex sexual behavior, where the genetic correlation across sexes was found to be lower than for many other traits, suggesting only a partially shared genetic architecture. [2] Sex-specific genetic associations can manifest in several ways: a concordant effect direction (CED) where an association is present in one sex and nominally significant in the same direction in the other; a single sex effect (SSE) where an association is present only in one sex; or an opposite effect direction (OED) where an association is present in one sex and nominally significant in the opposite direction in the other. [3] Sex hormones also play a role, with genetic correlations observed with circulating sex hormone-binding globulin (SHBG) levels, which are inversely related to bioactive testosterone and estrogen. [2]
Clinical Relevance
The biological differences between sexes have profound implications for health and disease, influencing susceptibility, progression, and treatment responses. Genetic research highlights that sex-associated signals are often pleiotropic, meaning they are linked to multiple traits and health outcomes, including blood pressure, type 2 diabetes, anthropometry, bone mineral density, autoimmune diseases, personality traits, and psychiatric diseases. [1]
A critical aspect of clinical relevance lies in the potential for "sex-differential participation bias" in research studies. [1] If study participation is influenced differently by sex, autosomal variants associated with a phenotype can also appear associated with sex, potentially leading to incorrect conclusions, such as falsely identifying a causal relationship between a phenotype and sex using Mendelian randomization (MR) analysis. [1] Researchers must account for such biases, which can vary substantially between studies depending on recruitment design. [1] Recognizing and investigating sex-specific genetic associations is essential for precision medicine and for developing effective, tailored interventions for both sexes. [3]
Social Importance
The concept of biological sex is deeply interwoven with social structures and individual identities. While biological sex refers to physiological and genetic attributes, its interaction with social factors shapes human experience. Research into complex human behaviors, such as sexual orientation, acknowledges the "multifaceted richness and complexity" beyond simplified phenotypic definitions used in genetic studies. [2] The understanding that genetic influences on traits like same-sex sexual behavior are highly polygenic and involve many small-effect variants underscores the biological complexity that interacts with environmental and social factors. [2] These studies also highlight the importance of considering environmental factors, such as societal prejudice, when interpreting genetic correlations related to social behaviors. [2] A neutral and comprehensive understanding of biological sex from a genetic perspective contributes to informed discussions across scientific, medical, and social domains.
Methodological and Statistical Constraints
Research into biological sex faces significant methodological and statistical challenges that can impact the reliability and interpretation of findings. Sample sizes, particularly in sex-specific analyses, often lack sufficient power to detect subtle associations or gene-by-sex interactions, leading to a potential underestimation of sex-specific genetic effects. [4] Even when large cohorts are available, smaller sample sizes for one sex compared to the other can weaken statistical significance, meaning that observed male-specific associations might simply reflect a lack of power to detect similar associations in females. [3] This limitation necessitates the combination of results from different genome-wide association studies (GWAS) through sex-stratified meta-analyses to enhance statistical power and ensure robust discoveries. [3]
A pervasive issue is participation bias, where individuals who enroll in research studies are often not representative of the general population. [1] This sex-differential participation bias can lead to spurious autosomal associations with sex, creating artefactual heritability and potentially incorrect causal inferences in downstream analyses such as Mendelian randomization. [1] For example, if a trait influences participation rates differently between sexes, variants associated with that trait may appear spuriously associated with sex. [1] Such biases can inflate estimated causal effects and complicate the interpretation of sex-specific analyses, highlighting the critical need for careful consideration of recruitment designs and their impact on genetic findings. [1]
Generalizability and Phenotypic Definition Challenges
The generalizability of findings concerning biological sex is often limited by the demographic characteristics of study cohorts. Many analyses are restricted to specific ancestral groups, such as participants of white British ancestry, meaning results may not be broadly applicable to other populations. [5] Furthermore, the determinants of sex-differential participation bias can vary substantially between studies, as evidenced by contrasting genetic correlations for traits like educational attainment between different cohorts. [1] This variability underscores that findings from one population or study design may not accurately reflect patterns in others, necessitating diverse and inclusive research efforts.
Phenotypic definitions and measurement approaches also present limitations, particularly in distinguishing between biological sex and socially constructed gender. Many genetic analyses explicitly focus on biologically defined sex and, as a common practice, exclude individuals whose biological sex and self-identified sex/gender do not match. [2] This exclusion means that transgender and intersex persons, among other important groups, are not represented in these analyses, limiting the scope and inclusivity of the research. [2] Technical artifacts, such as autosomal genotype array probes cross-hybridizing with sex chromosome sequences, have also been identified as a source of false-positive associations with sex, requiring stringent quality control to prevent misinterpretation of biological mechanisms. [1]
Incomplete Genetic and Environmental Understanding
Despite advances in genetic research, significant gaps remain in fully understanding the genetic architecture of traits related to biological sex, particularly regarding missing heritability and environmental interactions. The entirety of family-based heritability is often not captured by measured single nucleotide polymorphisms (SNPs), with SNP-heritability typically being much lower than family-based estimates. [2] This discrepancy suggests that variants not captured by genotyping arrays, nonadditive genetic effects, or phenotypic heterogeneity contribute to the "missing heritability" and indicate that current genetic models may not fully account for the complex genetic influences on sex-related traits. [2]
Furthermore, environmental and gene–environment confounders pose considerable challenges. Large biobank studies, while powerful, often have limited measurements of early-life conditions and parental characteristics, making it difficult to fully address these potential confounding factors in analyses. [5] The interplay between autosomal and sex chromosome genes and their interaction with sex hormones remains an area needing further exploration. [3] Addressing these complex interactions requires multi-omics approaches and sex-specific experimental validation in cell lines and animal models, which are often lacking in initial GWAS findings. [4]
Variants
Genetic variants play a crucial role in shaping human traits, with many exhibiting sex-differential effects that influence how genes manifest in males and females. These differences can arise from complex interactions between genetic factors and biological sex, affecting various physiological processes, including body composition and neurological development. Studies have increasingly focused on identifying single nucleotide polymorphisms (SNPs) where genetic effects vary by sex or age, providing insights into the nuanced genetic architecture of complex traits. [6]
The FTO gene, associated with rs10468280, is a well-known locus with a significant impact on body mass index (BMI) and obesity risk. While the precise mechanism through which FTO influences energy balance is still under investigation, it is understood to play a role in regulating appetite and metabolism. The variant rs10468280 is a common polymorphism within FTO that has been consistently linked to increased BMI across diverse populations, and studies have shown FTO to have a large effect size on BMI, highlighting its substantial contribution to body size. The influence of such genetic factors on body size and shape can also vary by biological sex, with research indicating sex-specific genetic effects on traits like waist-to-hip ratio adjusted for BMI (WHRadjBMI). [6]
Other variants are implicated in diverse biological functions, many of which can have sex-specific implications. For example, DCC (rs7506909) plays a critical role in neuronal guidance during nervous system development, influencing axon pathfinding and brain structure. Variations in genes like DCC, LINGO2 (rs80028017), SETBP1 (rs269972), and SMARCA2 (rs10964391) can affect brain development, neuronal function, and transcriptional regulation, potentially contributing to sex differences observed in neurological or psychiatric conditions. The discovery of SNPs with sex-specific effects underscores the importance of considering biological sex in genetic studies, as genetic correlations between complex traits and sex can arise, sometimes influenced by sex-differential participation in research studies. [6]
Variants within genes involved in RNA processing and germ cell development also contribute to the intricate genetic landscape with potential sex-specific outcomes. MIR9-2HG (rs6452792) is a host gene for microRNA-9-2, which is involved in various cellular processes including neuronal differentiation and tumor suppression. DAZL (rs11710967) is crucial for germ cell development and fertility in both males and females, with its variants potentially influencing reproductive health. SRPK2 (rs73186025) encodes a protein kinase involved in mRNA splicing, a fundamental process for gene expression, while FIGN (rs357304) is involved in the regulation of actin dynamics and cell motility. The LINC01392 - POLR2DP2 region, including rs6968125, involves long intergenic non-coding RNAs and pseudogenes that can modulate gene expression. These genetic factors, through their broad biological roles, can exhibit partly different genetic influences in females and males, contributing to the observed sex-specific genetic architectures for various traits and behaviors. [6]
Key Variants
| RS ID | Gene | Related Traits |
|---|---|---|
| rs357304 | FIGN - PRPS1P1 | biological sex smoking initiation smoking status measurement |
| rs6452792 | MIR9-2HG | biological sex sexual activity behaviour attribute smoking behavior trait, risk-taking behaviour |
| rs10468280 | FTO | biological sex |
| rs11710967 | DAZL | biological sex |
| rs6968125 | LINC01392 - POLR2DP2 | biological sex insomnia smoking cessation |
| rs80028017 | LINGO2 - ME2P1 | biological sex |
| rs269972 | SETBP1 - SLC14A2 | biological sex |
| rs73186025 | SRPK2 | biological sex |
| rs7506909 | DCC | biological sex brain volume |
| rs10964391 | SMARCA2 | biological sex |
Core Definition and Operationalization
Biological sex, as utilized in genetic and epidemiological studies, is primarily understood and operationalized as a categorical variable, distinguishing individuals as either "male" or "female". [2] This categorization is fundamental for investigating sex-specific biological differences and genetic architectures. In research contexts, sex serves as a critical stratifying factor, allowing for the analysis of distinct patterns of genetic association and phenotypic expression within these groups. For instance, studies frequently create strata such as "men <50y," "men >50y," "women <50y," and "women >50y" to evaluate age- and sex-dependent effects on various traits. [6] This clear operational definition enables researchers to identify and quantify sex-differential impacts on health and disease.
Classification and Impact on Phenotypic Expression
The classification of individuals by biological sex is integral to understanding sexual dimorphism in human traits and disease susceptibility. Sex-specific classifications are essential for identifying genetic loci that exert different effects between males and females, as seen with anthropometric traits like Body Mass Index (BMI) and Waist-to-Hip Ratio adjusted for BMI (WHRadjBMI). [6] These studies reveal instances of "sex-different effects" and "sex-specific associations," highlighting that the genetic architecture of certain phenotypes can vary substantially between sexes. [6] Such classifications are not merely descriptive but are critical for uncovering distinct biological mechanisms, such as the enrichment of neural pathways versus insulin-related pathways in the genetics of BMI versus WHRadjBMI, respectively, which can exhibit sexual dimorphism. [6] The recognition of these sex-specific patterns guides the development of targeted interventions and a more nuanced understanding of disease etiology.
Terminology and Methodological Considerations in Genetic Research
In genetic research, specific terminology is employed to describe the role of biological sex, including "sex-differential effects," "sex-specific effects," and "sexual dimorphism," which denote variations in genetic influence or phenotypic expression between males and females. [6] Methodologically, sex is a key covariate in statistical models, frequently adjusted alongside age and other factors when analyzing traits such as circulating hormone levels, BMI, and waist-to-hip ratio. [7] The significance of "SNP*sex interaction terms" is often computed to determine if the effect of a genetic variant differs based on an individual's sex. [7] Furthermore, researchers address potential "sex-differential participation bias," where the representation or behavior of males and females in study cohorts may systematically differ, which can confound genetic correlation analyses. [1] Such precise terminology and methodological rigor are vital for accurately interpreting genetic findings and developing robust models of human health.
Biological Background of Biological Sex
Biological sex is a fundamental aspect of human biology, encompassing a complex interplay of genetic, hormonal, developmental, and physiological mechanisms. While the initial determination of biological sex is primarily rooted in chromosomal composition, its downstream effects permeate every level of biological organization, leading to profound differences in anatomy, physiology, disease susceptibility, and even the expression of various traits. Understanding these multifaceted biological underpinnings is crucial for comprehending human health and diversity.
Genetic Foundations and Sex-Differential Gene Expression
Biological sex, as a fundamental classification, is not determined by autosomal genes. Research often utilizes sex as a robust negative control precisely because it has no autosomal determinants, indicating its primary genetic basis lies on the sex chromosomes. However, the subsequent biological expression of various traits throughout the body is profoundly influenced by an individual's sex, leading to widespread sex-differential effects. [1] While biological sex itself is not autosomal, numerous genetic variants located on autosomes exhibit sex-specific effects, meaning their impact on a trait differs significantly between males and females. These gene-by-sex interactions represent critical regulatory networks, leading to distinct gene expression patterns and cellular functions across sexes, exemplified by differing genetic influences on complex traits like sexual behavior in males and females. [6]
Hormonal Regulation and Molecular Pathways
Key biomolecules, particularly hormones such as testosterone and estrogen, play a central role in mediating many of the biological differences between sexes. These hormones act as critical signaling molecules, binding to specific receptors within cells to trigger complex molecular and cellular pathways. This binding initiates cascades that influence metabolic processes, alter cellular functions, and modulate gene expression patterns across various tissues. The differential presence and activity of these hormones are responsible for a wide array of sex-specific biological outcomes, from reproductive development to the regulation of metabolism and behavior. [2]
Developmental Processes and Tissue-Organ Interactions
Biological sex significantly influences developmental processes, leading to distinct tissue and organ-level biology. For instance, there is a close developmental origin between fetal gonadotropin-releasing hormone and olfactory neurons, highlighting interconnected developmental pathways that can be impacted by sex. [2] Beyond initial development, sex-specific genetic effects can manifest differently across various tissues and organs, leading to varied outcomes. This means that a particular genetic variant might affect a specific organ's function or structure differently in males compared to females, shaping organ-specific effects and overall systemic consequences.
Sex-Specific Trait Expression and Pathophysiological Processes
The interplay of genetic mechanisms, hormonal influences, and developmental pathways results in a wide range of sex-specific trait expressions and pathophysiological processes. Genetic associations with traits like adult body size and shape, including body mass index (BMI) and waist-to-hip ratio, often exhibit significant sex-differential effects, with specific genetic loci having varying impacts between males and females. [6] In some cases, genetic variants can have entirely opposite effects depending on sex, as seen with rs2720555 where an additional minor allele decreases the odds of nonsyndromic orofacial clefts in males but increases them in females. [8] These sex-dependent genetic influences highlight how biological sex contributes to distinct disease mechanisms, developmental variations, and homeostatic disruptions, often requiring sex-specific approaches in understanding health and disease.
Hormonal Signaling and Transcriptional Control
Biological sex is fundamentally shaped by intricate hormonal signaling pathways that orchestrate gene expression and cellular function. The male sex-determining gene SRY initiates a cascade that includes the basic helix-loop-helix transcription factor TCF21 as a downstream target, influencing male sexual differentiation. [2] Gonadotropins, released from the pituitary, regulate the activity of Leydig cells in the testis, affecting the production of various serine proteases and their inhibitors, known as SERPINs, which are crucial for testicular function. [9] Furthermore, the regulation of sex hormone-binding globulin (SHBG) is pivotal, as it modulates the bioavailability of sex steroids and can act as an estrogen amplifier, influencing numerous physiological processes. [10]
Beyond primary sex hormones, broader endocrine interactions also play a role, such as the glucocorticoid-induced inactivation of androgens, mediated by enzymes like aldo-keto reductase 1C2. [6] These complex interactions involve receptor activation, intracellular signaling cascades, and transcription factor regulation, often operating within sophisticated feedback loops to maintain hormonal homeostasis. Genetic variants influencing sex hormone-related phenotypes, including the levels of sex hormones and gonadotropins themselves, highlight the genetic architecture underlying these regulatory processes. [10]
Metabolic Pathways and Sex-Specific Regulation
Sex-specific differences are evident in metabolic pathways, impacting energy metabolism, biosynthesis, and catabolism. Genetic factors contribute to sex-dimorphic effects on fasting glucose and insulin variability, suggesting distinct metabolic regulation between sexes. [11] For instance, genome-wide association studies have revealed a sex-specific association of CPS1 with coronary artery disease, indicating that metabolic vulnerabilities can differ based on biological sex. [12]
Further mechanistic insights into metabolic regulation emerge from studies identifying loci for type 2 diabetes through high-density imputation and islet-specific epigenome maps. [13] Dysregulation within these pathways can contribute to sex-biased disease risk, such as the association of an intergenic region near IPMK (rs72804706) with conditions like diabetic retinopathy. [14] These findings underscore the importance of understanding the sex-specific flux control and regulation within metabolic networks, as they contribute significantly to health and disease outcomes.
Diverse Regulatory Mechanisms and Genetic Interactions
The regulation of biological sex involves a rich array of mechanisms, including gene regulation, protein modification, and intricate genetic interactions. Gene expression itself exhibits significant sex differences, observed in the human peripheral blood transcriptome and influencing various traits. [6] These differences can arise from sex-specific trans-eQTLs and sex-specific epistasis, where the effects of genetic variants are modified by sex or by other genes in a sex-dependent manner. [14]
Beyond genetic sequence, epigenetic factors such as sex-biased methylation also contribute to differential gene regulation between sexes. [14] These mechanisms collectively ensure that the molecular machinery operates distinctly in male and female biological contexts, leading to divergent physiological responses. The interplay of these regulatory layers, encompassing gene expression, protein function, and epigenetic modifications, forms a complex web that defines sex-specific cellular identities and functions.
Systems-Level Integration and Phenotypic Outcomes
The pathways and mechanisms underlying biological sex do not operate in isolation but are integrated into complex biological networks, exhibiting pathway crosstalk and emergent properties. Genome-wide association studies reveal the polygenicity of traits, where numerous genetic variants with small effects collectively contribute to complex phenotypes, including those related to sex. [2] Sex-associated genetic signals often exhibit pleiotropic associations, meaning a single genetic variant can influence multiple traits, highlighting extensive network interactions. [1]
Systems-level analyses, such as Ingenuity Pathway Analysis, aid in identifying potential pathways, networks, and overlapping functions of genes that show sex-specific associations. [6] This integrative perspective helps understand how seemingly disparate molecular events converge to shape sex-specific physiology. For example, the genetic link between olfaction and reproductive function, as seen in Kallmann syndrome, illustrates how distinct physiological systems can be developmentally and functionally intertwined, leading to emergent sex-specific phenotypic outcomes. [2]
Sex-Differential Disease Susceptibility and Therapeutic Targets
Biological sex significantly influences susceptibility to various diseases and the efficacy of therapeutic interventions, often through sex-differential pathway dysregulation. Testosterone, for instance, has diverse disease impacts that vary between men and women, underscoring the need for sex-specific considerations in disease understanding. [15] Endocrine disorders like Polycystic Ovary Syndrome (PCOS) are highly sex-specific, involving complex hormonal imbalances and metabolic dysregulation, and require tailored management strategies. [16]
Furthermore, genetic susceptibility to common conditions like childhood asthma can be sex-specific, with particular polymorphisms, such as those in TSLP, showing differential associations in males and females. [17] Similarly, sex-specific risk alleles have been identified for nonsyndromic orofacial clefts, demonstrating how genetic predispositions interact with biological sex to influence disease presentation. [14] Understanding these sex-differential mechanisms is crucial for identifying novel therapeutic targets and developing sex-optimized treatments, as exemplified by the investigation of testosterone therapy for female sexual dysfunction. [18]
Sex-Differentiated Disease Susceptibility and Risk Assessment
Biological sex plays a crucial role in understanding disease susceptibility and refining risk assessment, influencing diagnostic utility across a wide range of health outcomes. Genetic analyses reveal that sex-associated signals are enriched for pleiotropic associations, meaning they are linked to multiple complex traits, including blood pressure, type 2 diabetes, anthropometry, bone mineral density, autoimmune diseases, personality traits, and psychiatric conditions. [1] This pleiotropy underscores the intricate ways biological sex contributes to the overall genetic architecture of disease, necessitating sex-stratified approaches for identifying high-risk individuals and developing more precise prevention strategies.
Specific genetic variants exhibit sex-specific associations, directly impacting risk stratification and personalized medicine. For instance, studies on renal cell carcinoma have identified sex-specific genetic susceptibility, where genetic associations can be present in one sex but not the other, or even show opposite effect directions. [3] Similarly, sex-specific loci have been identified for Barrett's Esophagus and Esophageal Adenocarcinoma, highlighting distinct genetic contributions to these conditions based on biological sex. [4] Mendelian randomization analyses have further elucidated sex-specific associations between circulating sex hormone levels and diseases such as type 2 diabetes, polycystic ovary syndrome (PCOS), prostate cancer, breast cancer, ovarian cancer, and endometrial cancer, alongside body composition traits. [15] These findings emphasize the importance of considering biological sex in diagnostic algorithms and risk prediction models to improve patient care.
Prognostic Value and Personalized Therapeutic Approaches
Biological sex offers significant prognostic value, aiding in the prediction of disease outcomes, progression, and individual responses to treatment, thereby guiding personalized therapeutic approaches. Genetic correlations for conditions like bipolar disorder, cannabis use, and the number of sexual partners have been observed to be significantly higher in females compared to males, suggesting sex-specific pathways influencing prognosis. [2] Furthermore, a significant genetic correlation exists between same-sex sexual behavior and serum sex-hormone-binding globulin (SHBG) levels in females, but not in males, which may reflect underlying sex-specific endocrine influences on health outcomes relevant to sexual behavior. [2] These insights can inform clinicians about potential sex-based differences in disease trajectories and help tailor monitoring strategies.
Understanding these sex-specific genetic influences is critical for selecting appropriate treatments and optimizing patient care. Multi-omics approaches that investigate interactions between autosomes, sex chromosomes, and sex hormones are essential to unravel the endogenous causes of sex bias in sexually dimorphic traits and diseases. [3] While research has identified sex-specific genetic associations, comprehensive functional validation, including sex-specific experimental studies in cell lines and animal models, is often required to translate these genetic findings into clinically actionable insights for treatment selection. [4] For example, the FTO locus, associated with obesity, shows a BMI-increasing allele at rs10468280 with a higher frequency in males compared to females in some populations, which could influence sex-differential responses to obesity interventions. [1]
Methodological Considerations in Sex-Specific Genetic Research
Conducting and interpreting sex-specific genetic analyses requires careful consideration of various methodological challenges, particularly concerning study design and potential biases. Large-scale biobank studies, while powerful, are often not designed to be representative of the general population, which can introduce sex-differential participation bias. [1] This bias occurs when study participation is influenced by a phenotype in a sex-differential manner, leading to autosomal variants associated with that phenotype also appearing associated with sex. [1] Such biases can result in spurious genetic correlations between traits or incorrect causal inferences in Mendelian randomization analyses, potentially exaggerating or attenuating true effects, especially for highly sex-differentiated traits like testosterone levels. [1]
The impact of sex-differential participation bias underscores the necessity for robust research methodologies and cautious interpretation of findings. For instance, studies have shown that even modest BMI-related sex-differential participation bias can lead to artificial sex differences in the association between BMI genetic scores and outcomes like type 2 diabetes, sometimes even reversing the direction of observed sex differences. [1] Adjusting for sex as a covariate may not fully mitigate these biases, especially as sample sizes grow. [1] Furthermore, technical constraints in studies, such as the inability to examine sex chromosomal associations or limited statistical power for detecting subtle sex-specific associations when analyzing sexes separately, can further complicate the identification of true sex-specific genetic effects. [3] It is also critical to distinguish between biologically defined sex and self-identified gender in genetic analyses, acknowledging that many studies, by design, exclude transgender or intersex individuals, which limits the generalizability of their findings. [2] Moreover, population biases, such as UK Biobank participants tending to be wealthier and healthier, can affect effect size estimates and limit the generalizability of results to other ancestry groups. [5]
Frequently Asked Questions About Biological Sex
These questions address the most important and specific aspects of biological sex based on current genetic research.
1. Why do my health risks seem different from my brother's, even in the same family?
Your biological sex influences your genetic architecture, meaning genetic factors for many traits can differ between males and females. Even with shared family genes, these sex-specific differences can lead to varying susceptibilities to diseases like type 2 diabetes or autoimmune conditions. This is because genetic influences on health are often sex-specific, affecting how genes are expressed and interact with your environment.
2. Does my biological sex mean certain medications will work differently for me?
Yes, biological differences between sexes can profoundly impact treatment responses. Genetic research highlights sex-associated signals that are pleiotropic, meaning they link to multiple traits and health outcomes. This can influence how your body processes and responds to medications, making sex-specific genetic associations crucial for precision medicine.
3. Is it true that men and women tend to get different types of diseases?
Yes, there are significant biological differences that influence susceptibility and progression of many diseases in a sex-specific manner. For instance, some autoimmune diseases are more common in one sex, while conditions like certain psychiatric diseases can also show sex-differential patterns due to underlying genetic influences. These sex-specific genetic architectures contribute to distinct health profiles.
4. Could my genes affect my personality differently because I'm a woman?
Your biological sex can indeed influence the genetic architecture of traits like personality. Genetic associations can manifest differently between sexes, meaning the genetic influences contributing to personality traits might not be entirely shared or could even have opposite effects in males versus females. This highlights how genetics interact with sex to shape individual characteristics.
5. Why does my doctor recommend different screenings for me than for a man?
This often stems from the biological differences between sexes, which impact disease susceptibility and progression. Genetic research shows that sex-associated signals are linked to various health outcomes, like bone mineral density or blood pressure, necessitating tailored screening and prevention strategies based on your biological sex.
6. Do my hormones play a bigger role in my disease risk than I thought?
Yes, hormones play a significant role and are interconnected with your genetic makeup. Genetic correlations have been observed with circulating sex hormone-binding globulin (SHBG) levels, which are inversely related to bioactive testosterone and estrogen. These hormonal differences, influenced by genetics, can affect a wide range of health outcomes and disease risks.
7. Why do some health studies not apply to my background?
Research findings can be limited by the demographics of study cohorts, with many analyses restricted to specific ancestral groups. This means results may not be broadly applicable to diverse populations, as the genetic determinants of health and even participation bias can vary significantly between different backgrounds.
8. Can exercise affect my health risks differently than my husband's?
While exercise is beneficial for everyone, the genetic architecture of many traits is sex-specific, meaning genetic influences can differ between males and females. This can lead to variations in how genetic predispositions interact with lifestyle factors like exercise, potentially influencing health outcomes such as anthropometry or disease risk differently for you.
9. Can my biological sex affect how I experience stress or anxiety?
Yes, genetic research indicates that sex-associated signals are linked to psychiatric diseases and personality traits. This suggests that the biological underpinnings of conditions like anxiety or stress response can have sex-specific genetic influences, leading to different experiences or susceptibilities between sexes.
10. Why does new health research sometimes not mention women/men specifically?
This can be due to methodological and statistical constraints in research. Sample sizes, especially for sex-specific analyses, often lack enough power to detect subtle associations in both sexes. This can lead to findings that appear specific to one sex or are generalized without explicit sex-stratified data, potentially underestimating sex-specific effects.
This FAQ was automatically generated based on current genetic research and may be updated as new information becomes available.
Disclaimer: This information is for educational purposes only and should not be used as a substitute for professional medical advice. Always consult with a healthcare provider for personalized medical guidance.
References
[1] Pirastu, N. "Genetic analyses identify widespread sex-differential participation bias." Nature Genetics, vol. 53, no. 6, 2021, pp. 770-776, doi:10.1038/s41588-021-00844-3.
[2] Ganna, A. et al. "Large-scale GWAS reveals insights into the genetic architecture of same-sex sexual behavior." Science, vol. 365, no. 6456, 2019, eaat7693. PMID: 31467194.
[3] Laskar, R. S., et al. "Sex specific associations in genome wide association analysis of renal cell carcinoma." Eur J Hum Genet, vol. 27, no. 10, 2019, PMID: 31231134.
[4] Dong, J., et al. "Sex-Specific Genetic Associations for Barrett's Esophagus and Esophageal Adenocarcinoma." Gastroenterology, 2020, PMID: 32918910.
[5] Harrison, S., et al. "Testosterone and socioeconomic position: Mendelian randomization in 306,248 men and women in UK Biobank." Sci Adv, vol. 7, no. 31, 2021, eabk0009.
[6] Winkler, T. W. et al. "The Influence of Age and Sex on Genetic Associations with Adult Body Size and Shape: A Large-Scale Genome-Wide Interaction Study." PLoS Genet, vol. 11, no. 9, 2015, e1005378. PMID: 26426971.
[7] Ortega-Azorin, Carolina, et al. "Candidate Gene and Genome-Wide Association Studies for Circulating Leptin Levels Reveal Population and Sex-Specific Associations in High Cardiovascular Risk Mediterranean Subjects." Nutrients, vol. 11, no. 11, 2019, p. 2788, doi:10.3390/nu11112788.
[8] Awotoye, W. et al. "Genome-wide Gene-by-Sex Interaction Studies Identify Novel Nonsyndromic Orofacial Clefts Risk Locus." J Dent Res, vol. 100, no. 13, 2021, pp. 1502-1510. PMID: 34689653.
[9] Odet, F; Verot, A; Le Magueresse-Battistoni, B. "The mouse testis is the source of various serine proteases and serine proteinase inhibitors (SERPINs): Serine proteases and SERPINs identified in Leydig cells are under gonadotropin regulation." Endocrinology, vol. 147, no. 9, 2006, pp. 4374–4383.
[10] Chen, Z; et al. "Genome-wide association study of sex hormones, gonadotropins and sex hormone-binding protein in Chinese men." J Med Genet, vol. 50, no. 12, 2013, pp. 794-801.
[11] Lagou, Vasiliki; Mägi, Reedik; Hottenga, Jouke-Jan J; et al. "Fasting glucose and insulin variability: sex-dimorphic genetic effects and novel loci." 2019.
[12] Coltell, O. et al. "Genome-Wide Association Study for Serum Omega-3 and Omega-6 Polyunsaturated Fatty Acids: Exploratory Analysis of the Sex-Specific Effects and Dietary Modulation in Mediterranean Subjects with Metabolic Syndrome." Nutrients, vol. 12, no. 2, 2020, p. 310. PMID: 31991592.
[13] Mahajan, A; et al. "Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps." Nat Genet, vol. 50, no. 11, 2018, pp. 1505–1513.
[14] Carlson, JC; et al. "Genome-wide interaction studies identify sex-specific risk alleles for nonsyndromic orofacial clefts." Genet Epidemiol, vol. 42, no. 7, 2018, pp. 696-709.
[15] Ruth, Katherine S., et al. "Genome-wide association study with 1000 genomes imputation identifies signals for nine sex hormone-related phenotypes." European Journal of Human Genetics, vol. 24, no. 12, 2016, pp. 1797-1802, doi:10.1038/ejhg.2016.71.
[16] Conway, G; et al. "The polycystic ovary syndrome: a position statement from the European Society of Endocrinology." Eur J Endocrinol, vol. 171, no. 4, 2014, pp. P1–P29.
[17] Espuela-Ortiz, A; et al. "Role of Sex on the Genetic Susceptibility to Childhood Asthma in Latinos and African Americans." J Pers Med, vol. 11, no. 11, 2021, p. 1140.
[18] Jayasena, CN; et al. "A systematic review of randomized controlled trials investigating the efficacy and safety of testosterone therapy for female sexual dysfunction in postmenopausal women." Clin Endocrinol (Oxf), vol. 90, no. 3, 2019, pp. 391–414.